反应详情

4-Chloro-5-isoquinolinesulfonyl chloride obtained in Reference Example 7 (131 mg) and 4-[1-(tert-butoxycarbonylamino)ethyl]piperidine (134 mg) prepared according to the method described in WO05/080394 were used in the method of Example 1-1, Step A instead of 4-bromo-5-isoquinolinesulfonyl chloride and (S)-3-(tert-butoxycarbonylamino)pyrrolidine, respectively, to obtain the title compound (211 mg).

1. customprepared